Search clinical trials for: pembrolizumab and lenvatinib
Total 271390 results
-
Peking Union Medical College HospitalCompletedCholangiocarcinoma | Biomarker | Combinational Immunotherapy | Liver Neoplasm Malignant PrimaryChina
-
National University Hospital, SingaporeRecruitingAdenocarcinomas | Recurrent GynecologicalSingapore
-
MedSIRMerck Sharp & Dohme LLCActive, not recruitingMetastatic Thymic Carcinoma | Thymoma Type B3Spain, France, Italy
-
University College, LondonMerck Sharp & Dohme LLCRecruitingHepatocellular CarcinomaUnited Kingdom
-
Peking Union Medical College HospitalRecruitingBiliary Tract Neoplasms ImmunotherapyChina
-
Tianjin Medical University Second HospitalRecruiting
-
Eisai Co., Ltd.Merck Sharp & Dohme LLCCompleted
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Not yet recruitingClassic Kaposi Sarcoma | Kaposi Sarcoma | Refractory Kaposi Sarcoma
-
Saint Petersburg State University, RussiaRecruitingAnaplastic Thyroid CancerRussian Federation
-
Shanghai Zhongshan HospitalActive, not recruitingCarcinoma, HepatocellularChina
-
Abramson Cancer Center at Penn MedicineMerck Sharp & Dohme LLCRecruitingRenal Cell CarcinomaUnited States
-
Peking University Cancer Hospital & InstituteNot yet recruitingMucosal Melanoma | Neoadjuvant TreatmentChina
-
National Taiwan University HospitalNot yet recruitingUnresectable Hepatocellular Carcinoma | Pembrolizumab | Stereotactic Body Radiotherapy | LenvatinibTaiwan
-
Merck Sharp & Dohme LLCRecruitingSolid Tumor | Endometrial Cancer | Cutaneous Squamous Cell CarcinomaCanada, Australia, Taiwan, Malaysia, United States, Netherlands, Turkey, France
-
Eisai Co., Ltd.Merck Sharp & Dohme LLCCompletedHepatocellular CarcinomaUnited States, Spain, France, Italy, Japan, Russian Federation, United Kingdom
-
Medical University InnsbruckMerck Sharp & Dohme LLCRecruitingNon Small Cell Lung CancerAustria
-
RenJi HospitalRecruitingLiver Transplant; Complications | Hepatocellular Carcinoma RecurrentChina
-
University of Texas Southwestern Medical CenterRecruiting
-
National Cancer Center, KoreaMSD Korea Ltd.Enrolling by invitationAdrenocortical CarcinomaKorea, Republic of
-
Shanghai Jiahui International HospitalShanghai Zhongshan HospitalRecruitingAdvanced Biliary Tract CarcinomaChina
-
Merck Sharp & Dohme LLCEisai Inc.CompletedAdvanced MelanomaCanada, United States, Australia, Spain, Sweden
-
MedivirActive, not recruitingHepatocellular Carcinoma | Intrahepatic Cholangiocarcinoma | Liver MetastasesKorea, Republic of, Spain, Belgium, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingSmall Cell Lung CarcinomaPoland, Russian Federation, United States, Australia, Austria, Canada, Hungary, Israel, Italy, Korea, Republic of, Spain, Switzerland
-
Bristol-Myers SquibbRecruitingAdvanced Renal Cell Carcinoma (aRCC)United States
-
M.D. Anderson Cancer CenterSTRATEGIC ALLIANCE: MerckRecruiting
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingCarcinoma, HepatocellularUnited States, Australia, Canada, Chile, China, Colombia, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Russian Federation, Spain, Taiwan, Thailand, Turkey, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLCRecruitingMerkel Cell Carcinoma | Neuroendocrine Carcinoma of the Skin | Trabecular Carcinoma of the SkinUnited States
-
Elizabeth K. Lee MDMerck Sharp & Dohme LLCRecruitingGynecologic Cancer | Ovarian Clear Cell CarcinomaUnited States
-
Imperial College LondonNot yet recruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingStage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Stage IIA Pancreatic Cancer AJCC v8 | Stage IIB Pancreatic Cancer AJCC v8 | Advanced Pancreatic Ductal Adenocarcinoma | Unresectable Pancreatic Ductal AdenocarcinomaUnited States
-
Institut für Klinische Krebsforschung IKF GmbH...Merck Sharp & Dohme LLC; Medizinische Hochschule Hannover, Germany, Prof. Dr...Active, not recruitingHepatocellular CarcinomaGermany
-
Saint Petersburg State University, RussiaWithdrawnPoorly Differentiated Thyroid Gland Carcinoma | Metastatic Thyroid Gland Carcinoma | Thyroid Gland Anaplastic Carcinoma by AJCC V8 StageRussian Federation
-
Hospital of MacerataRecruiting
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruiting
-
M.D. Anderson Cancer CenterRecruitingRecurrent Primary Peritoneal High Grade Serous Adenocarcinoma | High Grade Ovarian Serous Adenocarcinoma | Recurrent High Grade Fallopian Tube Serous Adenocarcinoma | Recurrent High Grade Ovarian Serous Adenocarcinoma | High Grade Fallopian Tube Serous Adenocarcinoma | Peritoneal High Grade...United States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedPoorly Differentiated Thyroid Gland Carcinoma | Recurrent Differentiated Thyroid Gland Carcinoma | Columnar Cell Variant Thyroid Gland Papillary Carcinoma | Follicular Variant Thyroid Gland Papillary Carcinoma | Metastatic Thyroid Gland Follicular Carcinoma | Metastatic Thyroid Gland Papillary... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingClinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPoorly Differentiated Thyroid Gland Carcinoma | Thyroid Gland Squamous Cell Carcinoma | Unresectable Thyroid Gland Carcinoma | Metastatic Thyroid Gland Carcinoma | Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8 | Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8United States
-
Memorial Sloan Kettering Cancer CenterCompletedHead and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Head and Neck Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNon-small Cell Lung CancerChina, Israel, United States, Australia, Canada, Colombia, Estonia, France, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Poland, Russian Federation, Taiwan, Turkey, Ukraine
-
RenJi HospitalNot yet recruitingPediatric Cancer | Liver Cancer | Hepatoblastoma | Pediatric Solid Tumor | Transitional Cell TumorChina
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMalignant MelanomaUnited States, Australia, Austria, Brazil, Canada, Chile, China, France, Germany, Israel, Italy, Korea, Republic of, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingUrothelial CarcinomaHungary, United States, Argentina, Australia, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
National Cancer Centre, SingaporeMSD Pharma (Singapore) Pte LtdRecruitingHormone Receptor-Positive HER2-Negative Advanced Breast CancerSingapore
-
Peking University First HospitalMerck Sharp & Dohme LLCNot yet recruitingAdvanced Non-squamous Non-small-cell Lung Cancer | Metastatic Non-squamous Non Small Cell Lung Cancer | Recurrent Non-Squamous Non-Small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced Hepatocellular CarcinomaUnited States, China, Italy, Japan, Korea, Republic of, Poland, Spain, Switzerland, Taiwan
-
National Cancer Center, JapanMerck Sharp & Dohme LLCRecruitingUntreated Advanced or Recurrent Thymic CarcinomasJapan
-
Merck Sharp & Dohme LLCEisai Inc.CompletedNon-small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingColorectal NeoplasmsUnited States, Argentina, Australia, Canada, China, Denmark, Germany, Israel, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Shanghai Chest HospitalMerck Sharp & Dohme LLCRecruiting